Header Logo

Connection

DONALD PARSONS to Recombinant Proteins

Back to Details
This is a "connection" page, showing publications DONALD PARSONS has written about Recombinant Proteins.
DONALD PARSONS
Connection Strength
0.035
Recombinant Proteins
  1. Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report. Neuro Oncol. 2020 11 26; 22(11):1696-1704.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.